GPC Biotech Aims To Bring Satraplatin To Market This Year
This article was originally published in The Pink Sheet Daily
Executive Summary
Potential partners for the prostate cancer compound are “inundating” the company with offers, CEO tells BIO CEO & Investor Forum in New York.